Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goo, J. M.
Right arrow Articles by Chung, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goo, J. M.
Right arrow Articles by Chung, J.-K.
(Radiology. 2000;216:117-121.)
© RSNA, 2000


Nuclear Medicine

Pulmonary Tuberculoma Evaluated by Means of FDG PET: Findings in 10 Cases1

Jin Mo Goo, MD, Jung-Gi Im, MD, Kyung-Hyun Do, MD, Jeong Seok Yeo, MD, Joon Beom Seo, MD, Hyae Young Kim, MD and June-Key Chung, MD

1 From the Departments of Radiology and Institute of Radiation Medicine (J.M.G., J.G.I., K.H.D., J.B.S.) and Nuclear Medicine (J.S.Y., J.K.C.), Seoul National University Hospital, 28, Yongon-Dong, Chongno-Gu, Seoul, 110-744, South Korea; and the Department of Diagnostic Radiology, Ewha Womans University Mokdong Hospital, Seoul, South Korea (H.Y.K.). Received August 27, 1999; revision requested October 7; revision received November 2; accepted November 10. Address correspondence to J.G.I. (e-mail: imjg@radcom.snu.ac.kr).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: To describe findings of pulmonary tuberculoma at 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET).

MATERIALS AND METHODS: Ten consecutive patients who underwent PET and subsequently were proved to have pulmonary tuberculoma were analyzed. Tuberculosis was proved histopathologically in eight by means of wedge resection or lobectomy (n = 7) or needle biopsy (n = 1) and in two by means of clinical follow-up for more than 2 years. PET scans were evaluated by using peak standardized uptake values. Computed tomographic (CT) and histopathologic findings also were reviewed.

RESULTS: Nine of 10 tuberculomas showed FDG uptake at PET, and the mean peak standardized uptake value was 4.2 ± 2.2 (SD). FDG uptake (range, 1.9–3.7) in lesions adjacent to main abnormalities was demonstrated in four patients. On CT scans, the mean of the longest nodule diameters was 21 mm ± 8, and there were some areas of branching linear opacities or satellite nodules that suggested pulmonary tuberculosis in seven patients. Histopathologic findings were chronic granulomatous inflammation with caseation necrosis (n = 7) and healed tuberculosis with aspergilloma (n = 1).

CONCLUSION: Pulmonary tuberculoma commonly causes an increase in FDG uptake. These results suggest that in geographic regions with a high prevalence of granulomatous lesions, positive FDG PET results should be interpreted with caution in differentiating benign from malignant pulmonary abnormalities.

Index terms: Lung, CT, 60.12112, 60.12115 • Lung, diseases, 60.2056, 60.236 • Lung, granuloma, 60.20 • Lung, nodule, 60.3221 • Lung, PET, 60.12163 • Tuberculosis, pulmonary, 60.236


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Differentiation of malignant from benign pulmonary nodules is a common dilemma in diagnostic imaging. The primary objectives for treatment of patients with solitary pulmonary nodules are to expedite the removal of malignant lesions that may be curable surgically and to decrease the use of thoracotomy in benign entities.

Results of recent studies have shown that positron emission tomography (PET) with the glucose analogue 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) can be used to differentiate benign from malignant focal pulmonary abnormalities, including solitary pulmonary nodules and focal pulmonary masses (17). Although variations in uptake are known to exist among tumor types, elevated uptake of FDG has been demonstrated in all cell types of lung cancer (8,9). The sensitivities and specificities of those studies vary 83%–100% and 67%–90%, respectively (4,7,911). However, FDG is not a cancer-specific agent, and it has been reported that benign diseases related mainly to infection or inflammation also can show intense uptake, which causes difficulty in differentiating uptake due to benign disease from uptake due to malignant disease (4,5,7,11,12). The purpose of this study was to describe findings of pulmonary tuberculoma at FDG PET.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Data from FDG PET studies in 150 consecutive patients with focal pulmonary abnormalities were evaluated retrospectively. All patients had pulmonary abnormalities indeterminate for lung cancer on both chest radiographs and computed tomographic (CT) scans and were referred for evaluation of these abnormalities. Thirty-five patients had a history of lung cancer.

Among the 150 patients, the diagnosis of pulmonary tuberculoma was established in 10 patients (10 men; age range, 40–64 years; mean age, 53 years); pulmonary tuberculoma was diagnosed in eight patients on the basis of histopathologic findings and in two on the basis of clinical follow-up. The histopathologic diagnosis included wedge resection (n = 5), lobectomy (n = 2), and fine-needle aspiration (n = 1). The criteria for clinical diagnosis were based on CT findings suggestive of pulmonary tuberculosis (branching linear structures, satellite nodules, or a well-defined nodule with central calcification) that subsequently improved with the use of antituberculous chemotherapy during the follow-up of more than 2 years. Therefore, they were considered to have active pulmonary tuberculosis.

PET was performed with a scanner (ECAT EXACT 47; Siemens-CTI, Knoxville, Tenn) that has an intrinsic resolution of 5.2 mm and can image 47 contiguous, 3.4-mm-thick planes simultaneously for a longitudinal field of view of 16.2 cm. All patients fasted for at least 12 hours prior to the study; by means of skin marks, they were positioned carefully for each scan to ensure identical fields of view for transmission and emission scanning. Before administration of FDG, transmission scanning of the whole body, extending from the neck to the thigh, was performed by using a germanium 68 rod source for attenuation correction. Emission scans were obtained 60 minutes after the injection of 10 mCi (370 MBq) of FDG. Additional regional scans of the thorax were obtained for 30 minutes to image suspicious lesions. The acquired data were reconstructed by using standard back-projection techniques. PET images (257 transverse, 128 coronal, and 128 sagittal) were reconstructed by using measured attenuation correction and were corrected for decay.

Posteroanterior chest radiographs and thoracic CT scans were used to localize the abnormality before PET was performed. A qualified nuclear medicine physician (J.S.Y., J.K.C.) who was unaware of pathologic results but was aware of CT findings interpreted the PET scans. Images were reviewed in transverse, coronal, and sagittal planes by using an interactive video display system (SPARC station 10; Sun Microsystems, Mountain View, Calif). Interpretation included the semiquantification of FDG uptake by using the peak standardized uptake value on the emission images obtained 46–56 minutes after injection of FDG. After visually finding an area of the highest FDG uptake, the physician outlined a region of interest on the area of highest uptake. A standardized uptake value normalized for injected dose and body weight was obtained in each pixel by using a previously described method (37,11): standardized uptake value = region of interest activity/(injected dose/body weight), where the region of interest activity is measured in millicuries per milliliter, the injected dose is measured in millicuries, and body weight is measured in grams. The maximum pixel value in the region of interest was chosen as the peak standardized uptake value. Lesions that had a standardized uptake value of 2.5 or more were considered potentially malignant (57,11).

CT examinations were performed with a Somatom Plus 4 (Siemens, Erlangen, Germany) or a HiSpeed Advantage (GE Medical Systems, Milwaukee, Wis) scanner. Eight-millimeter-thick spiral CT sections were obtained from the pulmonary apex to the adrenal glands in all 10 patients. In nine patients, 100 mL of iopromide (Ultravist 370; Schering, Berlin, Germany) was injected intravenously. Additional 1-mm-thick CT scans also were obtained in three of the 10 patients. Both mediastinal window (width, 400 HU; level, 10 HU) and lung window (width, 1,500 HU; level, -700 HU) scans were obtained. The number of nodules and the presence of satellite nodules were analyzed on chest radiographs. The diameter, margin, and location of the nodule; the presence of calcification in the nodule; the presence of satellite nodules; associated parenchymal change around the nodule; and mediastinal lymph node enlargement were assessed on CT images. Histopathologic findings obtained from transthoracic fine-needle aspiration (n = 8) or from surgical specimens (n = 7) were reviewed.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Chest radiographic findings were a solitary pulmonary nodule (n = 6) or a pulmonary nodule associated with adjacent satellite nodules (n = 4) (Fig 1). Patients had no specific respiratory symptoms, except for two patients who had hemoptysis (n = 1) or dyspnea (n = 1). Eight patients were admitted to investigate an incidentally found pulmonary nodule. Associated diseases were diabetes mellitus (n = 1) and chronic renal failure (n = 1). One patient underwent right lower lobectomy owing to pulmonary abscess 20 years earlier. In one patient who had a history of antituberculous chemotherapy 2 years previously because acid-fast bacilli were found in sputum, a new nodule appeared during follow-up.



View larger version (102K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1a. Pulmonary tuberculosis in a 58-year-old man. (a) Posteroanterior chest radiograph shows two nodules (arrows) in the left upper pulmonary zone. The nodules nearly disappeared after 10 months of antituberculous chemotherapy. (b, c) Transverse thin-section CT scans of the left upper lobe show a nodule (solid straight arrow) 12 mm in diameter and branching linear opacity (curved arrow) in the inferior aspect of the nodule. There was another nodule in the left upper lobe (not shown). The nodular opacity (open arrow) in the left upper lobe adjacent to the mediastinum is a pulmonary vein, the posterior tributary (V3c) of the anterior segmental vein of the upper lobe. (d) Coronal FDG PET scan shows increased uptake (solid arrow) in the left upper lobe nodules that correspond to nodules on the chest radiograph. The standardized uptake values of the nodules were 4.2 (upper nodule) and 3.7 (lower nodule). The open arrow indicates normal cardiac uptake.

 


View larger version (109K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1b. Pulmonary tuberculosis in a 58-year-old man. (a) Posteroanterior chest radiograph shows two nodules (arrows) in the left upper pulmonary zone. The nodules nearly disappeared after 10 months of antituberculous chemotherapy. (b, c) Transverse thin-section CT scans of the left upper lobe show a nodule (solid straight arrow) 12 mm in diameter and branching linear opacity (curved arrow) in the inferior aspect of the nodule. There was another nodule in the left upper lobe (not shown). The nodular opacity (open arrow) in the left upper lobe adjacent to the mediastinum is a pulmonary vein, the posterior tributary (V3c) of the anterior segmental vein of the upper lobe. (d) Coronal FDG PET scan shows increased uptake (solid arrow) in the left upper lobe nodules that correspond to nodules on the chest radiograph. The standardized uptake values of the nodules were 4.2 (upper nodule) and 3.7 (lower nodule). The open arrow indicates normal cardiac uptake.

 


View larger version (153K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1c. Pulmonary tuberculosis in a 58-year-old man. (a) Posteroanterior chest radiograph shows two nodules (arrows) in the left upper pulmonary zone. The nodules nearly disappeared after 10 months of antituberculous chemotherapy. (b, c) Transverse thin-section CT scans of the left upper lobe show a nodule (solid straight arrow) 12 mm in diameter and branching linear opacity (curved arrow) in the inferior aspect of the nodule. There was another nodule in the left upper lobe (not shown). The nodular opacity (open arrow) in the left upper lobe adjacent to the mediastinum is a pulmonary vein, the posterior tributary (V3c) of the anterior segmental vein of the upper lobe. (d) Coronal FDG PET scan shows increased uptake (solid arrow) in the left upper lobe nodules that correspond to nodules on the chest radiograph. The standardized uptake values of the nodules were 4.2 (upper nodule) and 3.7 (lower nodule). The open arrow indicates normal cardiac uptake.

 


View larger version (157K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1d. Pulmonary tuberculosis in a 58-year-old man. (a) Posteroanterior chest radiograph shows two nodules (arrows) in the left upper pulmonary zone. The nodules nearly disappeared after 10 months of antituberculous chemotherapy. (b, c) Transverse thin-section CT scans of the left upper lobe show a nodule (solid straight arrow) 12 mm in diameter and branching linear opacity (curved arrow) in the inferior aspect of the nodule. There was another nodule in the left upper lobe (not shown). The nodular opacity (open arrow) in the left upper lobe adjacent to the mediastinum is a pulmonary vein, the posterior tributary (V3c) of the anterior segmental vein of the upper lobe. (d) Coronal FDG PET scan shows increased uptake (solid arrow) in the left upper lobe nodules that correspond to nodules on the chest radiograph. The standardized uptake values of the nodules were 4.2 (upper nodule) and 3.7 (lower nodule). The open arrow indicates normal cardiac uptake.

 
At CT, the mean of the longest diameter of the nodules was 21 mm ± 8 (SD; range, 8–32 mm). The nodules were located in the upper lobes in seven patients and in the lower lobes in three patients. Two of three nodules of the lower lobes were in the superior segment. Nine nodules had a smooth, well-demarcated margin (Figs 1, 2), but one had a spiculated border (Fig 3). Punctate (n = 1) (Fig 2) or round (n = 1) calcifications in the nodule were found in two patients at CT. Satellite nodules or branching linear opacities (Fig 1) were found in seven patients, and bronchiectasis adjacent to the nodule was found in one. No substantially enlarged (short diameter more than 8 mm) lymph nodes were demonstrated at CT.



View larger version (93K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2a. Tuberculoma in a 54-year-old man with small but increased FDG uptake in lymph nodes. (a) Transverse contrast material-enhanced CT scan shows an oval nodule with punctate calcification (arrow) and patent bronchus (arrowhead) in the superior segment of the left lower lobe. There was no lymph node enlargement. (b) Transverse FDG PET scan shows increased uptake in the nodule (arrow) with a standardized uptake value of 6.3 and in mediastinal lymph nodes (arrowheads) with standardized uptake values of 3.5 and 3.0. Tuberculous lymphadenopathy was not confirmed because only wedge resection was performed.

 


View larger version (98K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2b. Tuberculoma in a 54-year-old man with small but increased FDG uptake in lymph nodes. (a) Transverse contrast material-enhanced CT scan shows an oval nodule with punctate calcification (arrow) and patent bronchus (arrowhead) in the superior segment of the left lower lobe. There was no lymph node enlargement. (b) Transverse FDG PET scan shows increased uptake in the nodule (arrow) with a standardized uptake value of 6.3 and in mediastinal lymph nodes (arrowheads) with standardized uptake values of 3.5 and 3.0. Tuberculous lymphadenopathy was not confirmed because only wedge resection was performed.

 


View larger version (80K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3a. Tuberculoma that mimicked lung cancer at both CT and PET in a 62-year-old man. (a) Transverse contrast-enhanced CT scan obtained with mediastinal window settings shows an oval nodule (solid arrow) in the left upper lobe and the left hilar lymph node (open arrow). (b) Transverse CT scan obtained with lung window settings at the same level as a shows a nodule (arrow) with spiculated margins that suggests lung cancer. (c) Transverse FDG PET scan shows increased uptake in the nodule (short arrow) with a standardized uptake value of 7.0 and in the hilar node (long arrow) with a standardized uptake value of 3.5. Tuberculoma and tuberculous lymphadenitis were confirmed histopathologically.

 


View larger version (119K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3b. Tuberculoma that mimicked lung cancer at both CT and PET in a 62-year-old man. (a) Transverse contrast-enhanced CT scan obtained with mediastinal window settings shows an oval nodule (solid arrow) in the left upper lobe and the left hilar lymph node (open arrow). (b) Transverse CT scan obtained with lung window settings at the same level as a shows a nodule (arrow) with spiculated margins that suggests lung cancer. (c) Transverse FDG PET scan shows increased uptake in the nodule (short arrow) with a standardized uptake value of 7.0 and in the hilar node (long arrow) with a standardized uptake value of 3.5. Tuberculoma and tuberculous lymphadenitis were confirmed histopathologically.

 


View larger version (101K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3c. Tuberculoma that mimicked lung cancer at both CT and PET in a 62-year-old man. (a) Transverse contrast-enhanced CT scan obtained with mediastinal window settings shows an oval nodule (solid arrow) in the left upper lobe and the left hilar lymph node (open arrow). (b) Transverse CT scan obtained with lung window settings at the same level as a shows a nodule (arrow) with spiculated margins that suggests lung cancer. (c) Transverse FDG PET scan shows increased uptake in the nodule (short arrow) with a standardized uptake value of 7.0 and in the hilar node (long arrow) with a standardized uptake value of 3.5. Tuberculoma and tuberculous lymphadenitis were confirmed histopathologically.

 
In all but one patient with an 8-mm nodule, FDG uptake was identified at PET. The mean peak standardized uptake value for the nodules was 4.2 ± 2.2 (range, 0–7.0). FDG uptake (range, 1.9–3.7) also was seen within the lesions adjacent to the main abnormality in four patients (Fig 1). In three patients, there was FDG uptake within the lesions (range, 3.0–3.5) in the hilar or mediastinal area (Figs 2, 3), and one of these patients showed no FDG uptake in the pulmonary nodule.

Transthoracic fine-needle aspiration was performed in eight patients. In three patients, chronic granulomatous inflammation with caseation necrosis was seen at histologic examination, which was consistent with tuberculosis. In two of these three patients, wedge resection was performed because avid FDG uptake with standardized uptake values of 6.6 and 6.3 was observed at PET. The histologic findings at fine-needle aspiration in the remaining five patients were sheets of epithelioid cells and lymphocytes (n = 1), necrotic debris with scanty cells (n = 3), and a few macrophages (n = 1). Histopathologic findings in surgical specimens (n = 7) were chronic granulomatous inflammation with caseation necrosis (n = 6) and aspergilloma with fibrotic lesions and granuloma (n = 1), which was consistent with healed tuberculosis. In two of three cases in which Ziehl-Neelsen stain was used, acid-fast bacilli were found in the surgical specimens. Tuberculous lymphadenitis was found histopathologically in one patient.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Tuberculoma typically appears as a fairly discrete nodule or mass in which repeated extensions of infection have created a core of caseous necrosis surrounded by a mantle of epithelioid cells and collagen with peripheral round cell infiltration (13). The majority of tuberculomas are less than 3 cm in diameter (14), although lesions up to 5 cm have been reported (15). Small, discrete shadows in the vicinity of the main lesion (satellite lesions) may be identified in as many as 80% of cases (14). The tuberculomas are usually smooth in outline but may have a rough edge on CT scans (16,17). Calcification is found in 20%–30% of the lesions and is usually nodular or diffuse (16). The presence of benign-looking calcification within the nodule, adjacent tree-in-bud lesions (18), or satellite nodules may help in differentiating tuberculomas from malignant nodules. However, it frequently is hard to differenting tuberculomas from malignant nodules radiologically. The nodule with a spiculated margin in our study also strongly suggested the possibility of malignancy at CT (Fig 3).

Most solitary pulmonary nodules are benign (19); results from a surgical series showed that only one-third of solitary pulmonary nodules are bronchogenic carcinoma (20). Surgery is probably not warranted in the remaining two-thirds of solitary pulmonary nodules. Among these benign nodules, 54% are granuloma (20). The goals for imaging in patients with indeterminate pulmonary nodules are to distinguish between benign and malignant lesions in the least invasive way and to make a specific diagnosis.

FDG PET can demonstrate the glucose metabolism of a lesion, which can be helpful in differentiating between benign and malignant pulmonary lesions. Malignant cells demonstrate higher glucose metabolic activity than benign lesions do. A threshold standardized uptake value of 2.5 at FDG PET has been reported to provide optimal sensitivity (83%–100%) and specificity (67%–90%) in differentiating benign from malignant nodules in patients with solitary pulmonary nodules (4,7,911). However, by using this threshold, 90% of tuberculomas were false-positive for malignant nodules in our series. Only one tuberculoma, which was 8 mm in diameter, showed no identifiable FDG uptake. In South Korea, the prevalence of pulmonary tuberculosis on chest radiographs was 1.0% in 1995 (21). Our results substantiate that positive FDG PET results should be interpreted with caution in differentiating benign from malignant nodules, especially in patient groups with a high prevalence of tuberculosis.

Active granulomatous processes such as tuberculosis (5,7,12), fungal infections (4,11), and sarcoidosis (22) have been reported to accumulate FDG and cause PET scans false-positive for malignancy. However, most reported cases of uptake are in patients with lymphadenopathy, consolidation, or diffuse infiltrates, and the quantitative data concerning FDG uptake are available in only a few cases, to our knowledge. Knight et al (7) reported tuberculous pneumonia with a standardized uptake value of 9.3 and a tuberculoma with a standardized uptake value of 8.7. Gupta et al (11) reported that two granulomas with histoplasmosis showed FDG uptake with standardized uptake values of 1.92 and 3.38.

Granulomatous lesions are characterized by cellular infiltrates, granuloma formation, and macrophage proliferation. Activated inflammatory cells have markedly increased glycolysis, and the hexose monophosphate shunt is stimulated by phagocytosis, with increases of 20–30 times baseline values common in these stimulated cells (23). Even within tumors, the totality of FDG uptake is not completely within the tumor cells themselves. The newly formed granulation tissue around the tumor and the macrophages infiltrating heavily at the marginal areas surrounding the necrotic area of the tumor show a high uptake of FDG, and about 24% of the FDG concentration in a tumor mass is derived from nontumor tissue (24). FDG uptake is more rapid in inflammatory cells (25), and avid FDG uptake is the rule in inflammatory tissue, in which the uptake is predominantly in the cellular component. In tuberculosis, the cellular infiltrate is composed of lymphocytes and macrophages.

An experimental study on the tissue distribution of accumulated FDG in inflammatory tissue showed a maximum uptake was observed in the chronic phase, characterized histologically by chronic inflammation (26). Grain counting at microautoradiography of the abscess wall showed that the highest grain density was found in the marginal zone of young fibroblasts, endothelial cells of vessels, and phagocytes of neutrophils and macrophages (26). This suggests that macrophages and neutrophils in inflammatory tissue use glucose as an energy source for chemotaxis and phagocytosis, whereas fibroblasts use the same substance for proliferation.

In our series, FDG uptake (range, 1.9–3.7) within lesions adjacent to a main abnormality was demonstrated in four patients, and these areas of uptake correlated with the satellite nodules on CT scans. Lymph nodes that showed FDG uptake were found in three patients, and tuberculous lymphadenitis was demonstrated histopathologically in one. In one patient, FDG uptake was not identified in a pulmonary nodule, but the hilar lymph nodes showed uptake. We think that FDG uptake at PET can be considered indicative of active tuberculous lesions. Histopathologic findings suggested healed tuberculosis in one case, but the presence of aspergilloma may have caused the active inflammation.

In summary, our results show that tuberculomas can have increased FDG uptake at PET. FDG uptake within satellite lesions adjacent to a main abnormality or within lymph nodes also can occur. Therefore, positive results at FDG PET should be interpreted with caution in differentiating benign from malignant pulmonary abnormalities, especially in geographic regions with a high prevalence of granulomatous lesions.


    FOOTNOTES
 
Abbreviation: FDG = 2-[fluorine 18]fluoro-2-deoxy-D-glucose

Author contributions: Guarantors of integrity of entire study, J.M.G., J.G.I., J.K.C.; study concepts, J.M.G., J.G.I., J.B.S.; study design, J.M.G., J.B.S.; definition of intellectual content, J.M.G., J.G.I., J.K.C.; literature research, J.M.G., K.H.D., H.Y.K.; clinical studies, J.M.G., J.G.I., K.H.D., J.B.S., J.S.Y., J.K.C.; data acquisition, K.H.D., J.S.Y., J.M.G.; data analysis, J.M.G., K.H.D., H.Y.K.; manuscript preparation, J.M.G., J.B.S.; manuscript editing, J.M.G., J.S.Y., J.G.I.; manuscript review, J.G.I., J.M.G., J.S.Y., H.Y.K., J.K.C.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Som P, Atkins HL, Bandoypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose [18F]: nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21:670-675.[Abstract/Free Full Text]
  2. Gallagher BM, Fowler JS, Gutterson NI, et al. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19:1154-1161.[Abstract/Free Full Text]
  3. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184:441-444.[Abstract/Free Full Text]
  4. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management. Chest 1993; 104:997-1002.[Abstract/Free Full Text]
  5. Patz EF, Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188:487-490.[Abstract/Free Full Text]
  6. Patz EF, Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994; 191:379-382.[Abstract/Free Full Text]
  7. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET: comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109:982-988.[Abstract/Free Full Text]
  8. Wahl RL, Hutchins GD, Buschsbaum DJ, et al. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts: feasibility studies for cancer imaging with positron emission tomography. Cancer 1991; 67:1544-1550.[Medline]
  9. Kubota K, Matsauzawa J, Fijiwaar T, et al. Differential diagnosis of lung cancer with positron emission tomography: a prospective study. J Nucl Med 1990; 31:1927-1933.[Abstract/Free Full Text]
  10. Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995; 110:130-139.[Abstract/Free Full Text]
  11. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37:943-948.[Abstract/Free Full Text]
  12. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23:739-742.[Medline]
  13. Sochocky S. Tuberculoma of the lung. Am Rev Tuberc Pulmonary Dis 1958; 78:403-410.
  14. Steele JD. The solitary pulmonary nodule. J Thorac Cardiovasc Surg 1963; 46:21-39.
  15. Palmer PES. Pulmonary tuberculosis: usual and unusual radiographic presentations. Semin Roentgenol 1979; 14:204-242.[Medline]
  16. Lee KS, Im JG. CT in adult with tuberculosis of the chest: characteristic findings and role in management. AJR Am J Roentgenol 1995; 164:1361-1367.[Abstract/Free Full Text]
  17. Lee KS, Song KS, Lim TH, Kim PN, Kim IY, Lee BH. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am J Roentgenol 1993; 160:753-758.[Abstract/Free Full Text]
  18. Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings—early active disease and sequential change with antituberculous therapy. Radiology 1993; 186:653-660.[Abstract/Free Full Text]
  19. Khouri NF, Meziane MA, Zerhouni EA, Fishman EK, Siegelman SS. The solitary pulmonary nodule: assessment, diagnosis and management. Chest 1987; 91:128-133.[Abstract/Free Full Text]
  20. Swensen SJ, Jett JR, Payne WS, Viggiano RW, Pairolero PC, Trastek VF. An integrated approach to evaluation of the solitary pulmonary nodule. Mayo Clin Proc 1990; 65:173-186.[Medline]
  21. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998; 2:27-36.[Medline]
  22. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35:1647-1649.[Abstract/Free Full Text]
  23. Amrein PC, Larson SM, Wagner HN, Jr. An automated system for measurement of leukocyte metabolism. J Nucl Med 1975; 15:352-355.[Abstract/Free Full Text]
  24. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.[Abstract/Free Full Text]
  25. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994; 35:104-112.[Abstract/Free Full Text]
  26. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36:1301-1306.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
Y. J. Jeong and K. S. Lee
Pulmonary Tuberculosis: Up-to-Date Imaging and Management
Am. J. Roentgenol., September 1, 2008; 191(3): 834 - 844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. Zou, M. Zhang, Q. Wang, D. Shang, L. Wang, and G. Yu
Quantitative Investigation of Solitary Pulmonary Nodules: Dynamic Contrast-Enhanced MRI and Histopathologic Analysis
Am. J. Roentgenol., July 1, 2008; 191(1): 252 - 259.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. M. Schuurmans, A. Ellmann, H. Bouma, A. H. Diacon, K. Dyckmans, and C. T. Bolliger
Solitary pulmonary nodule evaluation with 99mTc-methoxy isobutyl isonitrile in a tuberculosis-endemic area
Eur. Respir. J., December 1, 2007; 30(6): 1090 - 1095.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
J. Burrill, C. J. Williams, G. Bain, G. Conder, A. L. Hine, and R. R. Misra
Tuberculosis: A Radiologic Review
RadioGraphics, September 1, 2007; 27(5): 1255 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y.-C. Lien, M.-T. Huang, and H.-C. Lin
Association Between Surgeon and Hospital Volume and In-Hospital Fatalities After Lung Cancer Resections: The Experience of an Asian Country
Ann. Thorac. Surg., May 1, 2007; 83(5): 1837 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Yuksel, A. G. Akgul, S. Evman, and H. F. Batirel
Suture and stapler granulomas: a word of caution
Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 563 - 565.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. M. Blodgett, C. C. Meltzer, and D. W. Townsend
PET/CT: Form and Function
Radiology, February 1, 2007; 242(2): 360 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. Kono, K. Fujimoto, H. Terasaki, N. L. Muller, S. Kato, J. Sadohara, N. Hayabuchi, and S. Takamori
Dynamic MRI of Solitary Pulmonary Nodules: Comparison of Enhancement Patterns of Malignant and Benign Small Peripheral Lung Lesions
Am. J. Roentgenol., January 1, 2007; 188(1): 26 - 36.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. J. Jeong, C. A. Yi, and K. S. Lee
Solitary Pulmonary Nodules: Detection, Characterization, and Guidance for Further Diagnostic Workup and Treatment
Am. J. Roentgenol., January 1, 2007; 188(1): 57 - 68.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. S. Shim, K. S. Lee, B.-T. Kim, J. Y. Choi, M. J. Chung, and E. J. Lee
Focal Parenchymal Lung Lesions Showing a Potential of False-Positive and False-Negative Interpretations on Integrated PET/CT.
Am. J. Roentgenol., March 1, 2006; 186(3): 639 - 648.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. Mahfouz, M.H. Miceli, F. Saghafifar, S. Stroud, L. Jones-Jackson, R. Walker, M.L. Grazziutti, G. Purnell, A. Fassas, G. Tricot, et al.
18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes
J. Clin. Oncol., November 1, 2005; 23(31): 7857 - 7863.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
M. R. Acker and S. C. Burrell
Utility of 18F-FDG PET in Evaluating Cancers of Lung
J. Nucl. Med. Technol., June 1, 2005; 33(2): 69 - 74.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
N. Aide, J.-F. Deux, I. Peretti, L. Mabille, J. Mandet, P. Callard, and J.-N. Talbot
Persistent Foreign Body Reaction Around Inguinal Mesh Prostheses: A Potential Pitfall of FDG PET
Am. J. Roentgenol., April 1, 2005; 184(4): 1172 - 1177.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. J. Lynch, C. D. Wright, N. C. Choi, S. L. Aquino, and E. J. Mark
Case 26-2004 - A 56-Year-Old Woman with Cough and a Lung Nodule
N. Engl. J. Med., August 19, 2004; 351(8): 809 - 817.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Asad, S. L. Aquino, N. Piyavisetpat, and A. J. Fischman
False-Positive FDG Positron Emission Tomography Uptake in Nonmalignant Chest Abnormalities
Am. J. Roentgenol., April 1, 2004; 182(4): 983 - 989.
[Full Text] [PDF]


Home page
ChestHome page
T. Hara, N. Kosaka, T. Suzuki, K. Kudo, and H. Niino
Uptake Rates of 18F-Fluorodeoxyglucose and 11C-Choline in Lung Cancer and Pulmonary Tuberculosis: A Positron Emission Tomography Study
Chest, September 1, 2003; 124(3): 893 - 901.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Demura, T. Tsuchida, T. Ishizaki, S. Mizuno, Y. Totani, S. Ameshima, I. Miyamori, M. Sasaki, and Y. Yonekura
18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax
J. Nucl. Med., April 1, 2003; 44(4): 540 - 548.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Ohno, H. Hatabu, D. Takenaka, S. Adachi, M. Kono, and K. Sugimura
Solitary Pulmonary Nodules: Potential Role of Dynamic MR Imaging in Management—Initial Experience
Radiology, August 1, 2002; 224(2): 503 - 511.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Ishimori, T. Saga, M. Mamede, H. Kobayashi, T. Higashi, Y. Nakamoto, N. Sato, and J. Konishi
Increased 18F-FDG Uptake in a Model of Inflammation: Concanavalin A-Mediated Lymphocyte Activation
J. Nucl. Med., May 1, 2002; 43(5): 658 - 663.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goo, J. M.
Right arrow Articles by Chung, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goo, J. M.
Right arrow Articles by Chung, J.-K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE